AHFS Drug Information 2020

With extensive updated information on everything from management of opiate use disorder to orphan drugs, AHFS^® Drug Information^® 2020 Edition is a necessary addition to your pharmacy’s resources.

With expanded and revised content supported by more than 94,000 references and incorporating the advice of numerous subject matter experts, AHFS^® DI™ helps you protect your patients and your practice. It’s the only print compendium designated by the U.S. Congress, the only compendium published by a professional and scientific society, and is the reference that has been trusted by pharmacists and other healthcare professionals for over 60 years.

AHFS^® DI™ contains the most trustworthy drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Updates for this edition include:

• Management of opiate use disorder
• Multimodal pain management strategies, including expansion of information related to non-opiate analgesic agents and opiate-sparing drugs; management of pain and sedation in critically ill patients, including current best practices such as the concept of analgosedation and comparisons of various sedative agents used for ICU sedation
• Newly published information on breakthrough oncology drugs approved as part of the FDA’s accelerated approval program
• Updating of pharmacogenomic considerations related to dosage adjustments (e.g., tamoxifen) or risk of sensitivity reactions (e.g., allopurinol, phenytoin or fosphenytoin)
• Updated information on non-oncology off-label uses (e.g., mycophenolate in treating scleroderma; ketamine use in treatment-resistant depression)

Your Comprehensive, Interactive Treatment and Drug Therapy Solution

A pharmacy professional’s indispensable digital tool, AHFS^® Clinical Drug Information™ lets you rapidly toggle between a quick summary of the essentials and a comprehensive monograph view. Mark your favorites for easy access and take notes throughout.

By linking directly and in context to 20 additional specialty databases, it expands your access to real-time drug and safety updates, including quick access to current drug shortages information. Learn more here.

Published by Authority of the Board of the AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS^®
American Hospital Formulary Service^®

EDITORIAL STAFF

Elaine K. Snow, BS Pharm, Editor-in-Chief

Jane Miller, PharmD, Senior Associate Editor

Linda Kester, MS, Associate Editor

Natalie A. Mendham, PharmD, Associate Editor

Olin H. Welsh, Jr., PharmD, Associate Editor

Joan D. Heydorn, BS, Assistant Editor

Shingyee Cindy Huang, PharmD, Assistant Editor

Lily L. Leu, PharmD, BCOP, Oncology Specialist Assistant Editor

Lisa M. Kohoutek, PharmD, BCPS, Assistant Editor for Injectables

Laura R. Kennedy, PharmD, BCPS, Senior Drug Information Analyst

Natalie C. Rosanelli, PharmD, Senior Drug Information Analyst

Kaitlin M. Harves, PharmD, BCPS, Drug Information Analyst

Jeffery Shick, BS Pharm, Senior Director, eHealth Solutions; Clinical Informaticist

Edward D. Millikan, PharmD, Director, Product Development and Maintenance, eHealth Solutions; Clinical Informaticist

Seth A. Strawbridge, PharmD, Clinical Informaticist, eHealth Solutions

Terry Wang, MBA, Software Engineer, eHealth Solutions

Elizabeth P. Shannon, BS, Project Manager

Susan Braun, BS Pharm, Contributing Editor

Gerald K. McEvoy, PharmD, Contributing Editor

Rachel L. Feinstein, PharmD, Contributor

Lindsey R. Harper, PharmD, Contributor

Jacqueline H. Kostick, PharmD, Contributor

Allie Berry, MS, Research Assistant

Gillian Hurley, BA, Administrative Assistant